CVS Group plc Block Listing Application (7588X)
December 22 2023 - 2:48AM
UK Regulatory
TIDMCVSG
RNS Number : 7588X
CVS Group plc
22 December 2023
22 December 2023
CVS Group plc
("CVS" or the "Company")
Block Listing Application
CVS, one of the UK's leading providers of integrated veterinary
services, announces that applications have been made to the London
Stock Exchange for the admission of 410,000 of its ordinary shares
of 0.2p each in the Company ("Ordinary Shares") to trading on
AIM.
The 410,000 Ordinary Shares will be reserved under block
listings with 350,000 Ordinary Shares to be added to the
preexisting CVS Group SAYE Plan block listing and are to be issued
in connection with the exercise of option awards under the terms of
the Company's SAYE Plan.
The remaining 60,000 Ordinary Shares are to be added to the
preexisting CVS Long Term Incentive Plan block listing and are to
be issued in connection with the grant, vesting and/or exercise of
awards under the terms of the Company's Long Term Incentive Plan
("LTIP").
When issued, the Ordinary Shares under the block listing will
rank pari passu with the Company's existing issued Ordinary Shares.
It is anticipated that the block-listed shares will be admitted on
28 December 2023.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418
8900
Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
About CVS Group plc ( www.cvsukltd.co.uk )
CVS Group is an AIM-listed provider of veterinary services in
the UK, Australia, the Netherlands and the Republic of Ireland. CVS
is focused on providing high quality clinical services to its
clients and their animals, with outstanding and dedicated clinical
teams and support colleagues at the core of its strategy.
The Group has c.500 veterinary practices across its four
markets, including nine specialist referral hospitals and 39
dedicated out-of-hours sites. Alongside the core Veterinary
Practices division, CVS operates Laboratories (providing diagnostic
services to CVS and third-parties), Crematoria (providing pet
cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business
("Animed Direct").
The Group employs c.9,000 personnel, including c.2,400
veterinary surgeons and c.3,300 nurses.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSPPGQCPUPWUMP
(END) Dow Jones Newswires
December 22, 2023 02:48 ET (07:48 GMT)
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Jul 2024 to Aug 2024
CVS (AQSE:CVSG.GB)
Historical Stock Chart
From Aug 2023 to Aug 2024